Novel coating for stents could lower odds of blood clotting

09/9/2013 | PhysiciansBriefing.com

A study in Arteriosclerosis, Thrombosis, and Vascular Biology found that coating stents with CTP synthase 1 inhibitors such as cyclopentenyl cytosine may help inhibit smooth muscle cell proliferation, potentially cutting the risk of blood clots. "Our study identified CTPS1 as a novel target for developing anti-neointima drugs that are SMC-sensitive but have little side-effect on re-endothelialization during vascular repair," researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC